Investigating how glypicans affect eye pressure and glaucoma
Official title: Role of Glypicans in Trabecular Meshwork Function, IOP, and Glaucoma
Funded at Duke University · NIH-10939330 · Data updated 2026-11-12
This study is looking at a protein called glypican-4 to see how it helps the eye's drainage system work better, which could lead to new treatments for lowering eye pressure and preventing glaucoma-related vision loss.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | September 30, 2024 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $496,633 |
| NIH project number | 1R01EY036373-01 |
| Project ID | NIH-10939330 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk of glaucoma, particularly those with ocular hypertension.
✕Less likely to help
Patients with glaucoma who are already receiving effective treatment may not see additional benefits from this research.
What this research studies
This research focuses on understanding the role of glypicans, specifically glypican-4, in the function of the trabecular meshwork, which is crucial for regulating intraocular pressure (IOP). By examining how these proteins influence cell adhesion and actomyosin activity, the study aims to identify new molecular targets for developing treatments that can lower IOP and potentially prevent glaucoma-related blindness. The approach includes both cellular and molecular analyses to uncover the mechanisms behind these processes. Patients may benefit from new therapies that arise from this research, which could lead to more effective management of glaucoma.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively lower eye pressure and reduce the risk of glaucoma-related blindness.
How similar studies have gone: Previous research has shown promise in targeting molecular mechanisms related to IOP regulation, suggesting that this approach could lead to significant advancements in glaucoma treatment.
Where this research is happening
-
Duke University
Durham, United States Active
Researchers
- Principal investigator: Rao, P Vasantha — Duke University
- Study coordinator: Rao, P Vasantha
Related research
Other NIH-funded projects on the same topics.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
Comparing tube positions in glaucoma implants to protect corneal cells
This trial compares two tube placements for glaucoma drainage implants to see which better protects corneal cells and controls eye pressure in people with uncontrolled glaucoma.
-
Automated topographic test for glaucoma detection and progression
A new automated method uses topographic structure-function mapping to help diagnose glaucoma earlier and track its progression in patients.
-
Using AI on eye scans and genes to predict glaucoma risk
This project uses artificial intelligence on eye scans, vision tests, and genetic information to find people most likely to develop or have worsening glaucoma.
-
AI-based glaucoma screening in community health centers
A new, easy-to-use AI screening approach will be tested in federally funded health centers to help identify people at risk for glaucoma, especially in communities with higher risk.
-
Understanding how glaucoma genes control eye cell function
A long-term research project will study how genetic factors affect eye cells in adults with glaucoma to uncover new ideas for protecting vision.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.